25 XP   0   0   10

Applied DNA Sciences Inc
Buy, Hold or Sell?

Let's analyse Applied DNA Sciences Inc together

PenkeI guess you are interested in Applied DNA Sciences Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Applied DNA Sciences Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Applied DNA Sciences Inc

I send you an email if I find something interesting about Applied DNA Sciences Inc.

Quick analysis of Applied DNA Sciences Inc (30 sec.)










What can you expect buying and holding a share of Applied DNA Sciences Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
15.0%

What is your share worth?

Current worth
$0.24
Expected worth in 1 year
$-0.05
How sure are you?
40.0%

+ What do you gain per year?

Total Gains per Share
$-0.29
Return On Investment
-71.1%

For what price can you sell your share?

Current Price per Share
$0.41
Expected price per share
$0.368 - $0.588
How sure are you?
50%

1. Valuation of Applied DNA Sciences Inc (5 min.)




Live pricePrice per Share (EOD)

$0.41

Intrinsic Value Per Share

$-5.89 - $-2.38

Total Value Per Share

$-5.65 - $-2.14

2. Growth of Applied DNA Sciences Inc (5 min.)




Is Applied DNA Sciences Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$4.1m$9.1m-$2.5m-39.5%

How much money is Applied DNA Sciences Inc making?

Current yearPrevious yearGrowGrow %
Making money-$1.8m-$1.7m-$104.6k-5.7%
Net Profit Margin-171.6%-34.8%--

How much money comes from the company's main activities?

3. Financial Health of Applied DNA Sciences Inc (5 min.)




4. Comparing to competitors in the Diagnostics & Research industry (5 min.)




  Industry Rankings (Diagnostics & Research)  


Richest
#118 / 148

Most Revenue
#119 / 148

Most Profit
#80 / 148

Most Efficient
#119 / 148

What can you expect buying and holding a share of Applied DNA Sciences Inc? (5 min.)

Welcome investor! Applied DNA Sciences Inc's management wants to use your money to grow the business. In return you get a share of Applied DNA Sciences Inc.

What can you expect buying and holding a share of Applied DNA Sciences Inc?

First you should know what it really means to hold a share of Applied DNA Sciences Inc. And how you can make/lose money.

Speculation

The Price per Share of Applied DNA Sciences Inc is $0.41. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Applied DNA Sciences Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Applied DNA Sciences Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.24. Based on the TTM, the Book Value Change Per Share is $-0.07 per quarter. Based on the YOY, the Book Value Change Per Share is $0.01 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Applied DNA Sciences Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.07-17.0%-0.16-39.4%-0.11-26.9%-0.17-40.4%-0.17-41.2%
Usd Book Value Change Per Share-0.04-10.7%-0.07-18.1%0.012.8%0.012.4%0.000.8%
Usd Dividend Per Share0.001.1%0.000.3%0.000.8%0.000.2%0.000.1%
Usd Total Gains Per Share-0.04-9.6%-0.07-17.8%0.013.5%0.012.6%0.000.9%
Usd Price Per Share0.62-1.06-1.42-3.19-2.63-
Price to Earnings Ratio-2.21--1.74--4.18--4.97--4.94-
Price-to-Total Gains Ratio-15.72--2.19--19.62-337.35-212.42-
Price to Book Ratio2.54-2.93-2.79-5.02-5.94-
Price-to-Total Gains Ratio-15.72--2.19--19.62-337.35-212.42-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.41
Number of shares2439
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.070.01
Usd Total Gains Per Share-0.070.01
Gains per Quarter (2439 shares)-177.8526.35
Gains per Year (2439 shares)-711.40105.41
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
111-723-72199795
222-1445-143218193200
334-2168-214326290305
445-2890-285435386410
556-3613-356544483515
667-4335-427653580620
778-5058-498762676725
889-5781-569870773830
9101-6503-640979869935
10112-7226-7120889661040

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.020.00.00.0%0.040.00.00.0%3.082.00.03.5%
Book Value Change Per Share1.03.00.025.0%3.09.00.025.0%8.012.00.040.0%16.024.00.040.0%31.049.05.036.5%
Dividend per Share1.00.03.025.0%3.00.09.025.0%6.00.014.030.0%6.00.034.015.0%6.00.079.07.1%
Total Gains per Share1.03.00.025.0%3.09.00.025.0%8.012.00.040.0%16.024.00.040.0%31.049.05.036.5%

Fundamentals of Applied DNA Sciences Inc

About Applied DNA Sciences Inc

Applied DNA Sciences, Inc., a biotechnology company, develops and commercializes technologies to produce and detect deoxyribonucleic acid (DNA) in the Americas, Europe, Asia, and internationally. It operates through three segments: Therapeutic DNA Production Services; MDx Testing Services; and DNA Tagging and Security Products and Services. The Therapeutic DNA Production Services segment develops and commercializes the LinearDNA platform, which enables a cell-free manufacture of high-fidelity synthetic DNA sequences for use in nucleic acid-based therapeutics. The MDx Testing Services segment provides clinical molecular diagnostics (MDx) testing and clinical laboratory testing services; COVID-19 testing services, including test scheduling, sample collection, and automated results reporting for higher education institutions, private clients, and businesses under the safeCircle trademark; polymerase chain reaction (PCR) for production and detection of DNA and RNA; and MDx test kits and related supplies, as well as Isotopic analysis testing services. The DNA Tagging and Security Products and Services segment offers SigNature Molecular Tags, which provides a methodology to authenticate goods within large and complex supply chains for materials, such as cotton, nutraceuticals, and other products; SigNify portable DNA readers and SigNify consumable reagent test kits; and fiberTyping, which uses PCR-based DNA detection to detect a product's naturally occurring DNA sequences for the purposes of product provenance authentication and supply chain security. The company was formerly known as Datalink Systems, Inc. and changed its name to Applied DNA Sciences, Inc. in 2002. Applied DNA Sciences, Inc. was founded in 1983 and is headquartered in Stony Brook, New York.

Fundamental data was last updated by Penke on 2024-03-20 09:58:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is cheap.

1.1. Profitability of Applied DNA Sciences Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Applied DNA Sciences Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Applied DNA Sciences Inc to the Diagnostics & Research industry mean.
  • A Net Profit Margin of -132.7% means that $-1.33 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Applied DNA Sciences Inc:

  • The MRQ is -132.7%. The company is making a huge loss. -2
  • The TTM is -171.6%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-132.7%TTM-171.6%+38.9%
TTM-171.6%YOY-34.8%-136.8%
TTM-171.6%5Y-258.2%+86.7%
5Y-258.2%10Y-283.3%+25.0%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-132.7%-5.2%-127.5%
TTM-171.6%-6.0%-165.6%
YOY-34.8%-1.8%-33.0%
5Y-258.2%-8.0%-250.2%
10Y-283.3%-4.4%-278.9%
1.1.2. Return on Assets

Shows how efficient Applied DNA Sciences Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Applied DNA Sciences Inc to the Diagnostics & Research industry mean.
  • -11.9% Return on Assets means that Applied DNA Sciences Inc generated $-0.12 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Applied DNA Sciences Inc:

  • The MRQ is -11.9%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -13.7%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-11.9%TTM-13.7%+1.8%
TTM-13.7%YOY-10.0%-3.7%
TTM-13.7%5Y-25.1%+11.4%
5Y-25.1%10Y-32.7%+7.6%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-11.9%-0.9%-11.0%
TTM-13.7%-0.8%-12.9%
YOY-10.0%-1.3%-8.7%
5Y-25.1%-1.2%-23.9%
10Y-32.7%-0.8%-31.9%
1.1.3. Return on Equity

Shows how efficient Applied DNA Sciences Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Applied DNA Sciences Inc to the Diagnostics & Research industry mean.
  • -27.9% Return on Equity means Applied DNA Sciences Inc generated $-0.28 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Applied DNA Sciences Inc:

  • The MRQ is -27.9%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -34.3%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-27.9%TTM-34.3%+6.4%
TTM-34.3%YOY-19.8%-14.5%
TTM-34.3%5Y-30.7%-3.6%
5Y-30.7%10Y-71.8%+41.0%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-27.9%-0.4%-27.5%
TTM-34.3%-0.3%-34.0%
YOY-19.8%-1.0%-18.8%
5Y-30.7%-1.7%-29.0%
10Y-71.8%-2.1%-69.7%

1.2. Operating Efficiency of Applied DNA Sciences Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Applied DNA Sciences Inc is operating .

  • Measures how much profit Applied DNA Sciences Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Applied DNA Sciences Inc to the Diagnostics & Research industry mean.
  • An Operating Margin of -721.3% means the company generated $-7.21  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Applied DNA Sciences Inc:

  • The MRQ is -721.3%. The company is operating very inefficient. -2
  • The TTM is -368.2%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-721.3%TTM-368.2%-353.1%
TTM-368.2%YOY-48.6%-319.6%
TTM-368.2%5Y-294.7%-73.4%
5Y-294.7%10Y-297.6%+2.8%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-721.3%-9.4%-711.9%
TTM-368.2%-0.1%-368.1%
YOY-48.6%3.3%-51.9%
5Y-294.7%0.3%-295.0%
10Y-297.6%-2.7%-294.9%
1.2.2. Operating Ratio

Measures how efficient Applied DNA Sciences Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Diagnostics & Research industry mean).
  • An Operation Ratio of 5.25 means that the operating costs are $5.25 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Applied DNA Sciences Inc:

  • The MRQ is 5.252. The company is inefficient in keeping operating costs low. -1
  • The TTM is 3.799. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ5.252TTM3.799+1.453
TTM3.799YOY1.611+2.188
TTM3.7995Y3.755+0.044
5Y3.75510Y4.731-0.976
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ5.2521.315+3.937
TTM3.7991.297+2.502
YOY1.6111.277+0.334
5Y3.7551.246+2.509
10Y4.7311.215+3.516

1.3. Liquidity of Applied DNA Sciences Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Applied DNA Sciences Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Diagnostics & Research industry mean).
  • A Current Ratio of 1.77 means the company has $1.77 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Applied DNA Sciences Inc:

  • The MRQ is 1.774. The company is able to pay all its short-term debts. +1
  • The TTM is 3.268. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ1.774TTM3.268-1.494
TTM3.268YOY3.876-0.608
TTM3.2685Y3.794-0.527
5Y3.79410Y3.577+0.218
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ1.7742.183-0.409
TTM3.2682.341+0.927
YOY3.8762.625+1.251
5Y3.7942.989+0.805
10Y3.5772.958+0.619
1.3.2. Quick Ratio

Measures if Applied DNA Sciences Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Applied DNA Sciences Inc to the Diagnostics & Research industry mean.
  • A Quick Ratio of 1.47 means the company can pay off $1.47 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Applied DNA Sciences Inc:

  • The MRQ is 1.472. The company is able to pay all its short-term debts with the most liquid assets. +1
  • The TTM is 2.983. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ1.472TTM2.983-1.511
TTM2.983YOY3.429-0.446
TTM2.9835Y3.373-0.391
5Y3.37310Y3.270+0.104
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ1.4721.310+0.162
TTM2.9831.437+1.546
YOY3.4291.764+1.665
5Y3.3731.952+1.421
10Y3.2702.080+1.190

1.4. Solvency of Applied DNA Sciences Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Applied DNA Sciences Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Applied DNA Sciences Inc to Diagnostics & Research industry mean.
  • A Debt to Asset Ratio of 0.58 means that Applied DNA Sciences Inc assets are financed with 58.4% credit (debt) and the remaining percentage (100% - 58.4%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Applied DNA Sciences Inc:

  • The MRQ is 0.584. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.563. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.584TTM0.563+0.021
TTM0.563YOY0.462+0.101
TTM0.5635Y0.539+0.024
5Y0.53910Y0.495+0.044
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5840.432+0.152
TTM0.5630.431+0.132
YOY0.4620.377+0.085
5Y0.5390.443+0.096
10Y0.4950.446+0.049
1.4.2. Debt to Equity Ratio

Measures if Applied DNA Sciences Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Applied DNA Sciences Inc to the Diagnostics & Research industry mean.
  • A Debt to Equity ratio of 136.7% means that company has $1.37 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Applied DNA Sciences Inc:

  • The MRQ is 1.367. The company is able to pay all its debts with equity. +1
  • The TTM is 1.311. The company is able to pay all its debts with equity. +1
Trends
Current periodCompared to+/- 
MRQ1.367TTM1.311+0.055
TTM1.311YOY0.877+0.434
TTM1.3115Y0.648+0.663
5Y0.64810Y1.085-0.437
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ1.3670.606+0.761
TTM1.3110.595+0.716
YOY0.8770.603+0.274
5Y0.6480.636+0.012
10Y1.0850.730+0.355

2. Market Valuation of Applied DNA Sciences Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Applied DNA Sciences Inc generates.

  • Above 15 is considered overpriced but always compare Applied DNA Sciences Inc to the Diagnostics & Research industry mean.
  • A PE ratio of -2.21 means the investor is paying $-2.21 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Applied DNA Sciences Inc:

  • The EOD is -1.471. Based on the earnings, the company is expensive. -2
  • The MRQ is -2.213. Based on the earnings, the company is expensive. -2
  • The TTM is -1.739. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.471MRQ-2.213+0.742
MRQ-2.213TTM-1.739-0.474
TTM-1.739YOY-4.178+2.439
TTM-1.7395Y-4.967+3.228
5Y-4.96710Y-4.943-0.024
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD-1.471-0.300-1.171
MRQ-2.213-0.567-1.646
TTM-1.739-0.341-1.398
YOY-4.178-0.242-3.936
5Y-4.967-0.129-4.838
10Y-4.9433.396-8.339
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Applied DNA Sciences Inc:

  • The EOD is -0.463. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -0.697. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is 5.923. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD-0.463MRQ-0.697+0.234
MRQ-0.697TTM5.923-6.620
TTM5.923YOY-8.452+14.375
TTM5.9235Y-4.201+10.124
5Y-4.20110Y-4.433+0.231
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD-0.463-0.460-0.003
MRQ-0.697-0.918+0.221
TTM5.923-1.763+7.686
YOY-8.452-3.236-5.216
5Y-4.201-2.150-2.051
10Y-4.433-3.427-1.006
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Applied DNA Sciences Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Diagnostics & Research industry mean).
  • A PB ratio of 2.54 means the investor is paying $2.54 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Applied DNA Sciences Inc:

  • The EOD is 1.686. Based on the equity, the company is underpriced. +1
  • The MRQ is 2.537. Based on the equity, the company is underpriced. +1
  • The TTM is 2.931. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.686MRQ2.537-0.850
MRQ2.537TTM2.931-0.394
TTM2.931YOY2.790+0.141
TTM2.9315Y5.024-2.093
5Y5.02410Y5.944-0.920
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD1.6862.021-0.335
MRQ2.5372.140+0.397
TTM2.9312.126+0.805
YOY2.7903.071-0.281
5Y5.0243.399+1.625
10Y5.9444.152+1.792
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Applied DNA Sciences Inc.

3.1. Institutions holding Applied DNA Sciences Inc

Institutions are holding 19.23% of the shares of Applied DNA Sciences Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31Vanguard Group Inc3.0844052369100
2023-12-31AMH Equity Ltd2.17920.205370000-217232-36.9925
2023-12-31Geode Capital Management, LLC0.8198013918700
2023-12-31BlackRock Inc0.59660101295-366-0.36
2023-12-31Silverberg Bernstein Capital Management LLC0.5790.057998301983010
2023-12-31Atria Wealth Solutions, Inc.0.47710.00068101000
2023-12-31State Street Corporation0.445707567700
2023-12-31Susquehanna International Group, LLP0.4261072354-67837-48.389
2023-12-31Raymond James & Associates0.293804987900
2023-12-31Foundations Investment Advisors, LLC0.10230.000317366173660
2023-12-31Northern Trust Corp0.09301579300
2023-12-31HM Payson & Co0.09070.00021540000
2023-12-31Natixis SA0.07970.00011352900
2023-12-31Creative Planning Inc0.061701046800
2023-12-31Wells Fargo & Co0.01720292550.1712
2023-12-31Cutler Group LP0.01650.0001280000
2023-12-31Tower Research Capital LLC0.01380233923390
2023-12-31Royal Bank of Canada0.010170000
2023-12-31Morgan Stanley - Brokerage Accounts0.0039065610.1527
2023-12-31Bank of America Corp0.0020341164.9231
Total 9.39250.26421594711-167407-10.5%

3.2. Funds holding Applied DNA Sciences Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-02-29Vanguard Total Stock Mkt Idx Inv2.0416034663300
2024-02-29Vanguard Institutional Extnd Mkt Idx Tr1.02210.000117353400
2024-01-31Fidelity Extended Market Index0.4340.00017368900
2023-09-30BlackRock Extended Mkt Composite0.25220.00044282800
2023-12-31BlackRock Extended Equity Market K0.22010.000237364-75-0.2003
2024-01-31Fidelity Total Market Index0.177103007600
2024-01-31Fidelity Series Total Market Index0.10301749300
2024-01-31Fidelity Nasdaq Composite Index0.09060.00011538300
2023-12-31NT Ext Equity Mkt Idx Fd - L0.06930.00011176200
2023-12-31Northern Trust Extended Eq Market Idx0.06930.00011176200
2023-12-31SSgA U.S. Extended Market Index Class I0.05490.0002931700
2024-02-29State St US Extended Mkt Indx NL Cl C0.05490.0003931700
2023-12-31Extended Equity Market Fund M0.02720.000246202205
2024-02-29Vanguard U.S. Eq Idx £ Acc0.02080352400
2023-12-31NT Ext Equity Mkt Idx Fd - NL0.02020343600
2023-12-31NT Ext Equity Mkt Idx Fd - DC - NL - T20.01630276050.1815
2023-12-31SSgA U.S. Total Market Index Strategy0.015802687-62-2.2554
2024-01-31Spartan Extended Market Index Pool E0.01420.0001241200
2023-12-31Northern Trust Wilshire 50000.0035059500
2023-12-31NT US Market Cap Idx Fd - L0.0035059500
Total 4.71060.0019799787+88+0.0%

3.3. Insider Transactions

Insiders are holding 12.318% of the shares of Applied DNA Sciences Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2020-06-26William W MontgomeryBUY1100005.25135000
2020-06-18William W MontgomeryBUY400005.25215000
2020-06-09William W MontgomeryBUY750005.25140000
2019-11-13William W. MontgomeryBUY750005.24
2019-09-16William W MontgomeryBUY66780.366024222
2019-08-22William W MontgomeryBUY4000000.275630900
2019-01-24William W MontgomeryBUY500000.475180900
2019-01-22William W MontgomeryBUY600000.445030900
2019-01-18William W MontgomeryBUY1000000.445030900
2019-01-07William W MontgomeryBUY4000000.454560900
2019-01-03William W MontgomeryBUY1540000.444560900
2018-12-31William W MontgomeryBUY300000.374560900
2014-11-20James A HaywardBUY769233.24

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Applied DNA Sciences Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.044-0.074+69%0.011-488%0.010-543%0.003-1425%
Book Value Per Share--0.2430.385-37%0.538-55%0.435-44%0.422-42%
Current Ratio--1.7743.268-46%3.876-54%3.794-53%3.577-50%
Debt To Asset Ratio--0.5840.563+4%0.462+26%0.539+8%0.495+18%
Debt To Equity Ratio--1.3671.311+4%0.877+56%0.648+111%1.085+26%
Dividend Per Share--0.0050.001+300%0.003+41%0.001+407%0.000+915%
Eps---0.070-0.162+132%-0.110+59%-0.166+138%-0.169+143%
Free Cash Flow Per Share---0.221-0.113-49%-0.118-47%-0.156-29%-0.139-37%
Free Cash Flow To Equity Per Share---0.223-0.100-55%0.149-250%0.010-2414%0.060-475%
Gross Profit Margin--1.0001.0000%1.0000%1.013-1%1.007-1%
Intrinsic Value_10Y_max---2.382--------
Intrinsic Value_10Y_min---5.889--------
Intrinsic Value_1Y_max---0.510--------
Intrinsic Value_1Y_min---0.609--------
Intrinsic Value_3Y_max---1.325--------
Intrinsic Value_3Y_min---1.824--------
Intrinsic Value_5Y_max---1.892--------
Intrinsic Value_5Y_min---3.024--------
Market Cap6961267.000-50%10472462.16018026285.790-42%24059666.835-56%54205348.685-81%44637044.747-77%
Net Profit Margin---1.327-1.716+29%-0.348-74%-2.582+95%-2.833+113%
Operating Margin---7.213-3.682-49%-0.486-93%-2.947-59%-2.976-59%
Operating Ratio--5.2523.799+38%1.611+226%3.755+40%4.731+11%
Pb Ratio1.686-50%2.5372.931-13%2.790-9%5.024-50%5.944-57%
Pe Ratio-1.471+34%-2.213-1.739-21%-4.178+89%-4.967+124%-4.943+123%
Price Per Share0.410-50%0.6171.062-42%1.417-56%3.193-81%2.629-77%
Price To Free Cash Flow Ratio-0.463+34%-0.6975.923-112%-8.452+1113%-4.201+503%-4.433+536%
Price To Total Gains Ratio-10.448+34%-15.718-2.192-86%-19.616+25%337.350-105%212.424-107%
Quick Ratio--1.4722.983-51%3.429-57%3.373-56%3.270-55%
Return On Assets---0.119-0.137+15%-0.100-16%-0.251+111%-0.327+174%
Return On Equity---0.279-0.343+23%-0.198-29%-0.307+10%-0.718+157%
Total Gains Per Share---0.039-0.073+86%0.015-370%0.011-463%0.004-1144%
Usd Book Value--4128402.0006540775.750-37%9127146.000-55%7385655.800-44%7172655.200-42%
Usd Book Value Change Per Share---0.044-0.074+69%0.011-488%0.010-543%0.003-1425%
Usd Book Value Per Share--0.2430.385-37%0.538-55%0.435-44%0.422-42%
Usd Dividend Per Share--0.0050.001+300%0.003+41%0.001+407%0.000+915%
Usd Eps---0.070-0.162+132%-0.110+59%-0.166+138%-0.169+143%
Usd Free Cash Flow---3757679.000-1922829.250-49%-2005541.500-47%-2649521.800-29%-2355689.775-37%
Usd Free Cash Flow Per Share---0.221-0.113-49%-0.118-47%-0.156-29%-0.139-37%
Usd Free Cash Flow To Equity Per Share---0.223-0.100-55%0.149-250%0.010-2414%0.060-475%
Usd Market Cap6961267.000-50%10472462.16018026285.790-42%24059666.835-56%54205348.685-81%44637044.747-77%
Usd Price Per Share0.410-50%0.6171.062-42%1.417-56%3.193-81%2.629-77%
Usd Profit---1182857.000-1821636.000+54%-1717026.000+45%-2578943.900+118%-2754850.625+133%
Usd Revenue--891164.0002248963.750-60%4816430.750-81%2394564.300-63%1818725.150-51%
Usd Total Gains Per Share---0.039-0.073+86%0.015-370%0.011-463%0.004-1144%
 EOD+3 -5MRQTTM+16 -19YOY+8 -275Y+10 -2610Y+10 -26

4.2. Fundamental Score

Let's check the fundamental score of Applied DNA Sciences Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-1.471
Price to Book Ratio (EOD)Between0-11.686
Net Profit Margin (MRQ)Greater than0-1.327
Operating Margin (MRQ)Greater than0-7.213
Quick Ratio (MRQ)Greater than11.472
Current Ratio (MRQ)Greater than11.774
Debt to Asset Ratio (MRQ)Less than10.584
Debt to Equity Ratio (MRQ)Less than11.367
Return on Equity (MRQ)Greater than0.15-0.279
Return on Assets (MRQ)Greater than0.05-0.119
Total3/10 (30.0%)

4.3. Technical Score

Let's check the technical score of Applied DNA Sciences Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose0.428
Total1/1 (100.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-12-312023-03-312023-06-302023-09-302023-12-31
Income Tax Expense  -1-36-3723-14-9-237653



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets9,913
Total Liabilities5,785
Total Stockholder Equity4,232
 As reported
Total Liabilities 5,785
Total Stockholder Equity+ 4,232
Total Assets = 9,913

Assets

Total Assets9,913
Total Current Assets4,590
Long-term Assets5,323
Total Current Assets
Cash And Cash Equivalents 3,359
Net Receivables 451
Inventory 377
Other Current Assets 403
Total Current Assets  (as reported)4,590
Total Current Assets  (calculated)4,590
+/-0
Long-term Assets
Property Plant Equipment 1,657
Intangible Assets 2,699
Long-term Assets Other 968
Long-term Assets  (as reported)5,323
Long-term Assets  (calculated)5,323
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities2,588
Long-term Liabilities3,197
Total Stockholder Equity4,232
Total Current Liabilities
Short-term Debt 510
Accounts payable 1,017
Other Current Liabilities 1,007
Total Current Liabilities  (as reported)2,588
Total Current Liabilities  (calculated)2,534
+/- 54
Long-term Liabilities
Capital Lease Obligations 1,117
Long-term Liabilities  (as reported)3,197
Long-term Liabilities  (calculated)1,117
+/- 2,080
Total Stockholder Equity
Common Stock14
Retained Earnings -303,630
Other Stockholders Equity 307,849
Total Stockholder Equity (as reported)4,232
Total Stockholder Equity (calculated)4,232
+/-0
Other
Capital Stock14
Cash and Short Term Investments 3,359
Common Stock Shares Outstanding 13,673
Current Deferred Revenue54
Liabilities and Stockholders Equity 9,913
Net Debt -2,242
Net Invested Capital 4,232
Net Working Capital 2,002
Property Plant and Equipment Gross 1,657
Short Long Term Debt Total 1,117



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302004-03-312003-12-312003-09-302003-06-302003-03-312002-12-312002-09-302002-06-302002-03-312001-12-312001-09-302001-06-302001-03-312000-12-312000-09-302000-06-302000-03-311999-12-311999-09-301999-06-301999-03-31
> Total Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
34
98
207
895
277
85
82
82
3,071
1,295
9,183
9,183
8,586
11,694
4,677
4,677
2,460
2,203
2,412
2,412
2,563
2,563
1,847
1,533
1,799
1,550
1,507
1,133
1,070
1,020
1,413
1,774
1,238
894
3,504
2,522
1,452
1,970
1,349
1,625
5,073
3,841
8,375
6,241
3,782
3,771
3,506
5,022
3,627
14,123
15,554
20,485
17,712
15,219
15,566
16,770
13,217
10,423
8,154
9,609
7,934
6,608
5,634
6,149
4,226
2,985
3,565
10,872
11,327
13,975
11,341
9,678
20,782
17,190
14,417
11,402
13,879
11,920
22,265
20,297
19,175
15,790
13,652
9,913
9,91313,65215,79019,17520,29722,26511,92013,87911,40214,41717,19020,7829,67811,34113,97511,32710,8723,5652,9854,2266,1495,6346,6087,9349,6098,15410,42313,21716,77015,56615,21917,71220,48515,55414,1233,6275,0223,5063,7713,7826,2418,3753,8415,0731,6251,3491,9701,4522,5223,5048941,2381,7741,4131,0201,0701,1331,5071,5501,7991,5331,8472,5632,5632,4122,4122,2032,4604,6774,67711,6948,5869,1839,1831,2953,07182828527789520798340000000000000000
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
26
79
193
624
198
0
2
2
2,975
1,192
44
44
81
2,108
1,350
1,350
116
174
526
526
789
789
295
174
564
357
340
74
160
181
242
638
274
293
3,032
2,218
1,204
1,807
1,102
1,399
4,839
2,561
7,207
5,075
2,702
2,715
2,363
4,135
2,300
13,018
11,535
16,494
14,939
12,143
11,352
13,314
9,749
8,144
6,241
7,774
6,104
4,828
4,002
4,600
2,763
1,605
2,146
9,638
9,979
12,155
9,078
6,540
17,419
13,696
11,298
8,499
11,156
9,268
19,943
18,332
15,380
12,240
8,127
4,590
4,5908,12712,24015,38018,33219,9439,26811,1568,49911,29813,69617,4196,5409,07812,1559,9799,6382,1461,6052,7634,6004,0024,8286,1047,7746,2418,1449,74913,31411,35212,14314,93916,49411,53513,0182,3004,1352,3632,7152,7025,0757,2072,5614,8391,3991,1021,8071,2042,2183,032293274638242181160743403575641742957897895265261741161,3501,3502,1088144441,1922,97522019862419379260000000000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
26
79
193
624
198
0
2
2
2,975
1,192
31
31
78
1,931
1,225
1,225
89
35
25
25
585
585
136
51
14
17
213
6
99
22
18
468
123
12
2,747
1,936
857
1,256
725
984
4,406
1,832
6,360
4,199
1,988
2,026
1,393
2,872
984
10,730
7,312
12,383
9,786
7,087
4,479
6,702
4,020
2,403
2,960
4,765
3,709
2,515
1,660
3,138
1,541
507
559
8,663
8,663
10,925
7,787
4,241
13,926
12,173
6,555
2,748
6,513
4,682
15,215
12,877
12,287
10,756
7,152
3,359
3,3597,15210,75612,28712,87715,2154,6826,5132,7486,55512,17313,9264,2417,78710,9258,6638,6635595071,5413,1381,6602,5153,7094,7652,9602,4034,0206,7024,4797,0879,78612,3837,31210,7309842,8721,3932,0261,9884,1996,3601,8324,4069847251,2568571,9362,747121234681822996213171451136585585252535891,2251,2251,9317831311,1922,97522019862419379260000000000000000
       Net Receivables 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
12
12
3
31
18
18
0
0
0
14
89
89
75
71
64
16
47
16
36
57
63
63
99
178
209
233
324
443
297
362
408
588
673
749
606
518
835
1,115
1,160
2,078
3,930
3,924
5,027
4,792
6,375
6,156
5,192
5,251
2,588
2,156
1,526
1,415
1,486
615
316
244
840
274
549
231
194
1,034
2,186
737
2,804
3,857
2,588
2,859
3,068
4,053
1,968
683
256
451
4512566831,9684,0533,0682,8592,5883,8572,8047372,1861,0341942315492748402443166151,4861,4151,5262,1562,5885,2515,1926,1566,3754,7925,0273,9243,9302,0781,1601,11583551860674967358840836229744332423320917899636357361647166471758989140001818313121200000000000000000000000000
       Other Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
147
107
107
27
139
0
501
115
115
83
52
486
323
79
52
25
103
161
106
52
103
76
50
24
108
80
52
25
142
174
126
108
171
135
149
156
210
293
187
126
137
200
133
183
113
367
540
575
603
635
622
591
545
605
618
678
555
599
721
586
356
569
593
644
555
1,058
925
759
525
389
403
4033895257599251,05855564459356935658672159955567861860554559162263560357554036711318313320013712618729321015614913517110812617414225528010824507610352106161103255279323486528311511550101392710710714700000000000000000000000000000
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
8
19
14
271
79
85
80
80
96
102
9,139
9,139
8,505
9,585
3,327
3,327
2,344
2,030
0
1,886
1,774
1,774
1,552
1,359
1,234
1,193
1,167
1,059
911
838
1,171
1,137
964
601
471
303
248
164
247
226
234
1,280
1,168
1,165
1,080
1,056
1,143
887
1,327
1,106
4,019
3,990
2,773
3,076
4,214
3,455
3,468
2,279
1,913
1,835
1,829
1,780
1,632
1,549
1,463
1,380
1,418
1,234
1,348
1,820
2,263
3,138
3,362
3,493
3,119
2,903
2,724
2,652
2,322
1,965
3,796
3,549
5,525
5,323
5,3235,5253,5493,7961,9652,3222,6522,7242,9033,1193,4933,3623,1382,2631,8201,3481,2341,4181,3801,4631,5491,6321,7801,8291,8351,9132,2793,4683,4554,2143,0762,7733,9904,0191,1061,3278871,1431,0561,0801,1651,1681,2802342262471642483034716019641,1371,1718389111,0591,1671,1931,2341,3591,5521,7741,7741,88602,0302,3443,3273,3279,5858,5059,1399,1391029680808579271141980000000000000000
       Property Plant Equipment 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
29
29
28
28
28
22
21
8
8
42
38
156
156
137
121
106
106
81
81
64
47
33
19
12
9
8
6
4
2
1
0
89
82
121
127
211
190
198
664
696
717
647
649
576
521
588
527
572
562
879
806
792
724
672
590
524
500
551
536
420
369
316
265
226
184
265
751
1,278
2,175
2,423
2,577
3,024
2,808
2,629
2,557
2,223
1,866
3,046
2,524
2,076
1,657
1,6572,0762,5243,0461,8662,2232,5572,6292,8083,0242,5772,4232,1751,2787512651842262653163694205365515005245906727247928068795625725275885215766496477176966641981902111271218289012468912193347648181106106121137156156384288212228282829290000000000000000000
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4
14
18
27
33
28
28
26
25
9,117
8,778
8,440
8,101
2,107
2,015
1,922
1,829
1,737
1,644
1,459
1,459
1,367
1,275
1,183
1,092
1,001
909
819
728
637
546
0
364
273
182
91
0
0
0
0
565
421
397
375
351
328
304
389
526
285
285
285
285
285
285
285
285
285
285
285
285
285
285
285
285
285
285
285
285
285
285
285
285
0
0
0
0
0
0
0
0
0
0
000000000028528528528528528528528528528528528528528528528528528528528528528528528552638930432835137539742156500009118227336405466377288199091,0011,0921,1831,2751,3671,4591,4591,6441,7371,8291,9222,0152,1078,1018,4408,7789,1172526282833271814400000000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,500
1,500
0
360
1,535
920
1,045
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000001,0459201,53536001,5001,500000000000000000000000000000000000000000000000000000000000000000000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4
14
18
27
33
28
28
26
25
9,117
9,117
8,440
8,101
2,107
2,107
1,922
1,829
1,737
1,737
1,459
1,459
1,367
1,275
1,183
1,092
1,001
909
819
728
637
546
0
364
273
182
91
0
0
0
0
565
421
397
375
351
328
304
389
526
1,599
1,584
1,549
1,564
1,526
1,465
1,404
1,343
1,042
986
930
897
864
832
799
767
735
702
721
689
605
582
559
536
0
0
0
0
0
0
0
0
2,699
2,699
2,6992,699000000005365595826056897217027357677998328648979309861,0421,3431,4041,4651,5261,5641,5491,5841,59952638930432835137539742156500009118227336405466377288199091,0011,0921,1831,2751,3671,4591,4591,7371,7371,8291,9222,1072,1078,1018,4409,1179,1172526282833271814400000000000000000
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
222
127
36
36
36
36
616
472
449
433
407
567
366
739
579
3,447
3,429
1,894
2,270
3,422
2,732
2,796
1,689
1,389
1,334
62
62
62
62
62
62
172
62
76
95
95
95
95
95
95
95
95
95
99
99
0
1,026
0
0
001,0260999995959595959595959576621726262626262621,3341,3891,6892,7962,7323,4222,2701,8943,4293,44757973936656740743344947261636363636127222000000000000000000000000000000000000000000000000000
       Deferred Long Term Asset Charges 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
288
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
110
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000110000000000000000002880000000000000000000000000000000000000000000000000000000000000000
> Total Liabilities 
0
0
0
1
1
1
1
1
1
1
0
0
0
0
0
119
178
349
785
895
1,406
2,121
4,788
4,788
2,292
1,545
2,596
2,596
10,252
14,096
14,263
14,263
21,677
15,191
14,356
14,356
16,007
16,007
15,884
13,863
1,995
2,470
3,254
4,017
4,197
3,536
3,011
3,578
3,362
4,868
4,499
3,876
638
654
592
8,323
8,844
1,533
3,759
4,358
4,103
3,460
4,975
1,721
1,671
1,623
2,987
2,489
2,684
3,033
5,200
4,588
3,926
2,405
1,296
1,470
2,226
3,550
4,879
5,383
4,960
4,774
4,413
3,648
4,058
5,196
5,632
3,955
2,162
1,606
3,304
3,010
6,233
5,126
9,356
11,139
9,207
8,595
8,779
5,785
5,7858,7798,5959,20711,1399,3565,1266,2333,0103,3041,6062,1623,9555,6325,1964,0583,6484,4134,7744,9605,3834,8793,5502,2261,4701,2962,4053,9264,5885,2003,0332,6842,4892,9871,6231,6711,7214,9753,4604,1034,3583,7591,5338,8448,3235926546383,8764,4994,8683,3623,5783,0113,5364,1974,0173,2542,4701,99513,86315,88416,00716,00714,35614,35615,19121,67714,26314,26314,09610,2522,5962,5961,5452,2924,7884,7882,1211,406895785349178119000001111111000
   > Total Current Liabilities 
0
0
0
1
0
0
0
1
1
1
0
0
0
0
0
119
178
260
696
806
1,317
2,032
4,788
4,788
2,292
1,545
2,596
2,596
2,787
5,091
9,732
9,732
12,857
10,723
14,356
14,356
16,007
16,007
15,884
13,863
1,995
2,470
3,254
4,017
4,197
2,880
2,792
3,358
3,362
4,868
4,499
3,876
638
654
592
809
810
1,533
1,115
1,535
1,735
1,608
3,878
1,721
1,671
1,623
2,667
2,169
2,684
3,033
4,085
3,993
3,221
2,405
1,296
1,470
2,226
3,117
2,822
2,733
2,220
1,974
2,246
1,509
1,850
2,448
4,266
2,919
2,130
1,575
3,272
2,979
3,633
4,284
4,185
3,330
3,655
2,891
2,845
2,588
2,5882,8452,8913,6553,3304,1854,2843,6332,9793,2721,5752,1302,9194,2662,4481,8501,5092,2461,9742,2202,7332,8223,1172,2261,4701,2962,4053,2213,9934,0853,0332,6842,1692,6671,6231,6711,7213,8781,6081,7351,5351,1151,5338108095926546383,8764,4994,8683,3623,3582,7922,8804,1974,0173,2542,4701,99513,86315,88416,00716,00714,35614,35610,72312,8579,7329,7325,0912,7872,5962,5961,5452,2924,7884,7882,0321,317806696260178119000001110001000
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
133
661
1,219
2,789
2,789
425
425
410
410
510
410
4,172
4,172
4,931
1,746
740
740
3,169
3,169
3,063
1,068
927
1,529
2,410
2,809
2,447
1,645
1,774
2,407
2,424
2,952
3,731
3,088
250
250
0
0
0
0
0
0
0
0
1,800
1,800
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
376
1,828
659
0
0
0
0
0
0
0
0
477
487
499
510
510499487477000000006591,8283760000000000000000000001,8001,800000000002502503,0883,7312,9522,4242,4071,7741,6452,4472,8092,4101,5299271,0683,0633,1693,1697407401,7464,9314,1724,1724105104104104254252,7892,7891,2196611330000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,800
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
376
1,828
659
0
0
0
0
0
0
0
0
0
0
0
0
0000000000006591,82837600000000000000000000001,80000000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
0
0
0
1
0
0
0
0
1
1
0
0
0
0
0
101
106
156
454
393
429
567
1,770
1,770
1,654
933
2,185
2,185
2,274
4,681
335
335
7,926
8,977
0
1,234
12,778
12,778
413
583
737
752
593
750
828
962
721
0
0
1,916
165
287
257
214
473
603
685
1,249
641
770
986
905
1,060
886
998
770
1,238
1,599
1,909
1,479
1,530
1,658
1,158
1,016
383
602
439
387
501
944
642
839
1,152
833
700
1,131
1,250
1,518
1,217
716
2,010
1,761
1,437
1,842
1,744
2,023
1,647
1,052
1,072
1,017
1,0171,0721,0521,6472,0231,7441,8421,4371,7612,0107161,2171,5181,2501,1317008331,1528396429445013874396023831,0161,1581,6581,5301,4791,9091,5991,2387709988861,0609059867706411,2496856034732142572871651,9160072196282875059375273758341312,77812,7781,23408,9777,9263353354,6812,2742,1852,1859331,6541,7701,770567429393454156106101000001100001000
       Other Current Liabilities 
0
0
0
0
0
0
0
0
-1
-1
0
0
0
0
0
18
72
105
242
280
227
245
229
229
213
186
0
54
2
0
5,225
5,225
0
8,977
0
12,381
0
0
12,408
12,213
331
189
250
458
922
272
296
951
939
1,316
603
500
131
331
119
206
125
285
326
440
333
355
870
311
446
648
1,147
512
725
705
717
543
738
714
561
525
583
432
464
414
373
332
465
221
478
1,018
1,353
754
563
606
981
761
1,802
1,686
1,878
1,033
1,248
1,076
1,198
1,007
1,0071,1981,0761,2481,0331,8781,6861,8027619816065637541,3531,0184782214653323734144644325835255617147385437177057255121,1476484463118703553334403262851252061193311315006031,31693995129627292245825018933112,21312,4080012,38108,97705,2255,22502540186213229229245227280242105721800000-1-100000000
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
1
1
0
0
0
0
0
101
106
89
89
89
89
89
0
4,559
2,079
1,358
0
2,596
7,464
9,005
4,531
4,531
8,820
4,468
0
1,975
16,007
16,007
3,477
1,651
1,664
2,281
3,003
3,559
3,275
656
220
221
2,424
3,552
3,896
3,375
507
489
473
7,514
8,034
1,249
2,643
2,823
2,367
1,852
1,096
1,410
1,225
975
320
320
1,959
2,328
1,116
595
705
1,691
735
945
1,644
433
2,057
2,650
2,741
2,800
2,167
2,139
2,208
2,748
1,366
1,036
31
31
31
31
2,599
841
5,171
7,809
5,552
5,704
5,934
3,197
3,1975,9345,7045,5527,8095,1718412,599313131311,0361,3662,7482,2082,1392,1672,8002,7412,6502,0574331,6449457351,6917055951,1162,3281,9593203209751,2251,4101,0961,8522,3672,8232,6431,2498,0347,5144734895073,3753,8963,5522,4242212206563,2753,5593,0032,2811,6641,6513,47716,00716,0071,97504,4688,8204,5314,5319,0057,4642,59601,3582,0794,55908989898989106101000001100000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
320
0
0
0
0
0
0
0
0
0
0
0
1,587
2,141
2,195
2,216
1,442
1,479
1,486
1,963
517
188
0
0
0
0
0
0
0
0
0
0
0
0
0000000000001885171,9631,4861,4791,4422,2162,1952,1411,58700000000000320000000000000000000000000000000000000000000000000000000000000000000
       Deferred Long Term Asset Charges 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
288
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
110
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000110000000000000000002880000000000000000000000000000000000000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
7,514
8,034
0
2,643
2,824
2,367
1,852
1,096
0
0
0
320
320
0
0
1,116
595
705
0
0
0
0
433
471
508
546
584
622
660
723
785
848
848
31
31
31
31
2,599
841
5,171
7,809
0
4,836
0
0
004,83607,8095,1718412,5993131313184884878572366062258454650847143300007055951,116003203200001,0961,8522,3672,8242,64308,0347,5140000000000000000000000000000000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
900
468
564
0
0
0
0
0
0
0
0
0
110
0
0
0
0
0
0
0
0
0
0
0
0
0
0
276
0
0
00276000000000000001100000000005644689000000000000000000000000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
0
0
0
-1
0
0
0
0
-1
-1
0
0
0
0
0
-119
-144
-251
-577
0
-1,128
-2,036
-4,707
-4,707
779
-250
6,587
6,587
-1,665
-2,402
-9,586
-9,586
-19,217
-12,987
0
-11,945
-13,444
-13,444
-14,038
-12,330
-196
-920
-1,747
-2,884
-3,127
-2,517
-1,598
-1,804
-2,124
-3,974
-995
-1,354
814
1,316
757
-6,698
-3,771
2,308
4,616
1,882
-320
311
-1,468
3,301
1,955
12,500
12,567
17,996
15,028
12,186
10,365
12,182
9,291
8,018
6,858
8,138
5,707
3,058
755
766
-734
-1,789
-841
7,231
7,275
8,785
5,718
5,729
18,626
15,588
11,114
8,392
7,647
6,796
12,912
9,162
10,009
7,249
4,951
4,232
4,2324,9517,24910,0099,16212,9126,7967,6478,39211,11415,58818,6265,7295,7188,7857,2757,231-841-1,789-7347667553,0585,7078,1386,8588,0189,29112,18210,36512,18615,02817,99612,56712,5001,9553,301-1,468311-3201,8824,6162,308-3,771-6,6987571,316814-1,354-995-3,974-2,124-1,804-1,598-2,517-3,127-2,884-1,747-920-196-12,330-14,038-13,444-13,444-11,9450-12,987-19,217-9,586-9,586-2,402-1,6656,5876,587-250779-4,707-4,707-2,036-1,1280-577-251-144-11900000-1-10000-1000
   Common Stock
0
0
0
0
0
0
0
0
0
0
1
1
1
1
1
1
2
2
2
10,225
10,451
11,044
11,991
11,991
67
66
112
112
119
119
121
121
121
160
0
180
197
197
205
238
261
262
275
275
297
334
346
350
352
353
473
513
591
627
646
657
684
734
787
808
809
827
14
17
17
21
22
24
24
24
24
26
26
27
27
30
30
30
30
36
38
38
1
3
4
5
5
6
7
7
7
7
8
9
13
13
13
13
14
14
14141313131398777765543138383630303030272726262424242422211717148278098087877346846576466275915134733533523503463342972752752622612382051971971800160121121121119119112112666711,99111,99111,04410,45110,2252221111110000000000
   Retained Earnings Total Equity0000000000-279,611-276,162-274,645-269,836-265,713-262,423-259,471-256,806-255,272-253,794-251,107-248,366-244,891-242,003-239,857-236,673-233,818-231,208-227,779-223,817-221,402-218,035-214,568-211,641-211,145-209,474-207,589-199,760-197,655-195,736-192,985-186,6940000000-161,856-157,4390000000000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-57
-3
55
300
104
-2
-1
-1
-1
-880
-37
20
20
-200
-200
-21
-21
-52
-67
-83
-83
-130
-130
-147
-164
-178
-192
-199
-201
-203
-205
-207
-209
-210
-211
-211
-218
-226
-238
-252
-273
-295
-338
-410
-492
-576
-666
-759
-845
-646
-744
-853
-956
-1,039
-1,161
-1,263
-1,364
-1,465
-1,565
-1,666
-1,666
0
0
-2,036
-2,036
0
0
-2,293
-2,293
0
0
-2,449
-2,449
0
0
0
0
0
0
0
0
0
0
0
0
000000000000-2,449-2,44900-2,293-2,29300-2,036-2,03600-1,666-1,666-1,565-1,465-1,364-1,263-1,161-1,039-956-853-744-646-845-759-666-576-492-410-338-295-273-252-238-226-218-211-211-210-209-207-205-203-201-199-192-178-164-147-130-130-83-83-67-52-21-21-200-2002020-37-880-1-1-1-210430055-3-57000000000000000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
153,112
160,388
0
0
0
0
0
0
0
190,523
194,060
194,607
197,139
198,278
210,872
211,412
223,624
224,187
232,539
233,039
233,564
234,159
239,934
240,472
242,809
243,504
247,965
247,680
247,919
249,090
251,838
253,022
253,445
255,963
266,699
269,694
274,493
275,549
280,369
294,781
295,191
0
0
0
0
0
0
0
0
0
0
0000000000295,191294,781280,369275,549274,493269,694266,699255,963253,445253,022251,838249,090247,919247,680247,965243,504242,809240,472239,934234,159233,564233,039232,539224,187223,624211,412210,872198,278197,139194,607194,060190,5230000000160,388153,1120000000000000000000000000000000000000000000000000
   Treasury Stock0000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
806
0
0
0
0
806
806
815
815
815
815
815
96
465
627
2,578
671
1,858
2,588
6,119
12,238
101,124
108,710
81,880
163,760
176,442
163,721
82,648
82,628
83,038
87,420
0
128,449
131,919
131,919
133,133
138,124
140,198
140,803
141,410
142,081
143,205
146,375
149,397
150,532
152,808
153,112
160,388
162,399
166,033
167,929
169,118
170,357
176,385
184,549
190,523
194,060
194,607
197,139
198,278
210,872
211,412
223,624
224,187
232,539
233,039
233,564
234,159
239,934
240,472
241,809
243,504
247,965
247,680
247,919
249,090
251,838
253,022
253,445
255,963
266,699
269,694
274,493
275,549
280,369
294,781
295,191
295,228
297,228
298,352
298,624
305,399
305,493
305,751
306,091
307,385
307,849
307,849307,385306,091305,751305,493305,399298,624298,352297,228295,228295,191294,781280,369275,549274,493269,694266,699255,963253,445253,022251,838249,090247,919247,680247,965243,504241,809240,472239,934234,159233,564233,039232,539224,187223,624211,412210,872198,278197,139194,607194,060190,523184,549176,385170,357169,118167,929166,033162,399160,388153,112152,808150,532149,397146,375143,205142,081141,410140,803140,198138,124133,133131,919131,919128,449087,42083,03882,62882,648163,721176,442163,76081,880108,710101,12412,2386,1192,5881,8586712,578627465968158158158158158068060000806000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-09-30)

Gross Profit (+$)
totalRevenue13,367
Cost of Revenue-7,834
Gross Profit5,5335,533
 
Operating Income (+$)
Gross Profit5,533
Operating Expense-16,487
Operating Income-10,953-10,953
 
Operating Expense (+$)
Research Development3,735
Selling General Administrative12,752
Selling And Marketing Expenses0
Operating Expense16,48716,487
 
Net Interest Income (+$)
Interest Income75
Interest Expense-0
Other Finance Cost-0
Net Interest Income75
 
Pretax Income (+$)
Operating Income-10,953
Net Interest Income75
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-10,023-11,808
EBIT - interestExpense = -11,808
-10,023
-9,947
Interest Expense0
Earnings Before Interest and Taxes (EBIT)-11,808-10,023
Earnings Before Interest and Taxes (EBITDA)-10,445
 
After tax Income (+$)
Income Before Tax-10,023
Tax Provision-0
Net Income From Continuing Ops-10,023-10,023
Net Income-9,947
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses24,321
Total Other Income/Expenses Net855-75
 

Technical Analysis of Applied DNA Sciences Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Applied DNA Sciences Inc. The general trend of Applied DNA Sciences Inc is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Applied DNA Sciences Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator StateBullish trend Bearish trend
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Applied DNA Sciences Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 0.5194 < 0.5213 < 0.588.

The bearish price targets are: 0.368.

Tweet this
Applied DNA Sciences Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Applied DNA Sciences Inc. The current mas is .

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Applied DNA Sciences Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Applied DNA Sciences Inc.

Applied DNA Sciences Inc Daily Moving Average Convergence/Divergence (MACD) ChartApplied DNA Sciences Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Applied DNA Sciences Inc. The current adx is .

Applied DNA Sciences Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Applied DNA Sciences Inc.

Applied DNA Sciences Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Applied DNA Sciences Inc.

Applied DNA Sciences Inc Daily Relative Strength Index (RSI) ChartApplied DNA Sciences Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Applied DNA Sciences Inc.

Applied DNA Sciences Inc Daily Stochastic Oscillator ChartApplied DNA Sciences Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Applied DNA Sciences Inc.

Applied DNA Sciences Inc Daily Commodity Channel Index (CCI) ChartApplied DNA Sciences Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Applied DNA Sciences Inc.

Applied DNA Sciences Inc Daily Chande Momentum Oscillator (CMO) ChartApplied DNA Sciences Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Applied DNA Sciences Inc.

Applied DNA Sciences Inc Daily Williams %R ChartApplied DNA Sciences Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Applied DNA Sciences Inc.

Applied DNA Sciences Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Applied DNA Sciences Inc.

Applied DNA Sciences Inc Daily Average True Range (ATR) ChartApplied DNA Sciences Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Applied DNA Sciences Inc.

Applied DNA Sciences Inc Daily On-Balance Volume (OBV) ChartApplied DNA Sciences Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Applied DNA Sciences Inc.

Applied DNA Sciences Inc Daily Money Flow Index (MFI) ChartApplied DNA Sciences Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Applied DNA Sciences Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-06DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2023-11-07CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-09STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-13CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-15DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-11-17STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-21DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-24WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-11-27STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-30STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-01STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-04BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-05SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-06STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-07RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-08CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-13STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-15STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-27STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-03MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-01-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-16WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-19STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-23CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-24WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-26STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-31STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-02-02STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-02-07SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-09CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-12STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-13STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-14CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-16DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-20WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-02-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-26DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-29MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-04CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-06CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-08STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-11STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-12MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-13CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-14ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-18RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-20SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-03-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-03-25STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-27MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.

6.3. Candlestick Patterns

Applied DNA Sciences Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Applied DNA Sciences Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose0.428
Total1/1 (100.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Applied DNA Sciences Inc with someone you think should read this too:
  • Are you bullish or bearish on Applied DNA Sciences Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Applied DNA Sciences Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Applied DNA Sciences Inc

I send you an email if I find something interesting about Applied DNA Sciences Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Applied DNA Sciences Inc.

Receive notifications about Applied DNA Sciences Inc in your mailbox!